Relative Timing of Influenza Disease by Age Group

Overview

Journal Vaccine

Specialty Allergy & Immunology

Date 2014 Oct 5

PMID 25280434

Citations 5

Authors

Timothy R Peters

Beverly M Snively

Cynthia K Suerken

Elizabeth Blakeney

Lauren Vannoy

Katherine A Poehling

Affiliations

Soon will be listed here.

Abstract

A detailed understanding of influenza movement in communities during yearly epidemics is needed to inform improved influenza control programs. We sought to determine the relative timing of influenza presentation and symptom onset by age group and influenza strain. Prospective, laboratory-confirmed surveillance was performed over three moderate influenza seasons in emergency departments and inpatient settings of both medical centers in Winston-Salem, NC. Influenza disease presented first in school age children through community epidemics of influenza A(H1N1)pdm09 and influenza B, and first in persons 5-49 years old for influenza A(H3N2). This finding indicates that influenza prevention in persons 5-49 years of age may be particularly important in influenza epidemic control.

Citing Articles

Clinical features and outcomes of influenza by virus type/subtype/lineage in pediatric patients.

Han S, Rhim J, Kang J, Lee K Transl Pediatr. 2021; 10(1):54-63.

PMID: 33633937 PMC: 7882295. DOI: 10.21037/tp-20-196.

Linking influenza epidemic onsets to covariates at different scales using a dynamical model.

Roussel M, Pontier D, Cohen J, Lina B, Fouchet D PeerJ. 2018; 6:e4440.

PMID: 29568702 PMC: 5845579. DOI: 10.7717/peerj.4440.

Deploying digital health data to optimize influenza surveillance at national and local scales.

Lee E, Arab A, Goldlust S, Viboud C, Grenfell B, Bansal S PLoS Comput Biol. 2018; 14(3):e1006020.

PMID: 29513661 PMC: 5858836. DOI: 10.1371/journal.pcbi.1006020.

2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.

Poehling K, Caspard H, Peters T, Belongia E, Congeni B, Gaglani M Clin Infect Dis. 2017; 66(5):665-672.

PMID: 29029064 PMC: 5850007. DOI: 10.1093/cid/cix869.

Synchronicity of influenza activity within Phoenix, AZ during the 2015-2016 seasonal epidemic.

Tamerius J, Steadman J, Tamerius J BMC Infect Dis. 2017; 17(1):109.

PMID: 28143437 PMC: 5286821. DOI: 10.1186/s12879-017-2197-z.

References

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E . Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2012; (8):CD004879. PMC: 6478137. DOI: 10.1002/14651858.CD004879.pub4. View

Glezen W, Couch R . Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978; 298(11):587-92. DOI: 10.1056/NEJM197803162981103. View

Jackson M, France A, Hancock K, Lu X, Veguilla V, Sun H . Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009. Clin Infect Dis. 2011; 53(5):455-62. DOI: 10.1093/cid/cir437. View

Doshi P, Abi-Jaoude E, Lexchin J, Jefferson T, Thomas R . Influenza vaccination of health care workers. CMAJ. 2013; 185(2):150. PMC: 3563890. DOI: 10.1503/cmaj.113-2096. View

Davis M, King Jr J, Moag L, Cummings G, Magder L . Countywide school-based influenza immunization: direct and indirect impact on student absenteeism. Pediatrics. 2008; 122(1):e260-5. DOI: 10.1542/peds.2007-2963. View

Manzoli L, Ioannidis J, Flacco M, De Vito C, Villari P . Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Hum Vaccin Immunother. 2012; 8(7):851-62. PMC: 3495721. DOI: 10.4161/hv.19917. View

. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2012; 61(32):613-8. View

Fiore A, Shay D, Broder K, Iskander J, Uyeki T, Mootrey G . Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008; 57(RR-7):1-60. View

10.

Monto A . Individual and community impact of influenza. Pharmacoeconomics. 2000; 16 Suppl 1:1-6. DOI: 10.2165/00019053-199916001-00001. View

11.

Jefferson T, Di Pietrantonj C, Debalini M, Rivetti A, Demicheli V . Inactivated influenza vaccines: methods, policies, and politics. J Clin Epidemiol. 2009; 62(7):677-86. DOI: 10.1016/j.jclinepi.2008.07.001. View

12.

Fiore A, Epperson S, Perrotta D, Bernstein H, Neuzil K . Expanding the recommendations for annual influenza vaccination to school-age children in the United States. Pediatrics. 2012; 129 Suppl 2:S54-62. DOI: 10.1542/peds.2011-0737C. View

13.

Gaglani M, Piedra P, Herschler G, Griffith M, Kozinetz C, Riggs M . Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med. 2004; 158(1):65-73. DOI: 10.1001/archpedi.158.1.65. View

14.

Ahout I, Ferwerda G, de Groot R . Influenza vaccination in kids, are you kidding me?. J Infect. 2013; 68 Suppl 1:S100-7. DOI: 10.1016/j.jinf.2013.09.019. View

15.

Yamashita M, Krystal M, FITCH W, Palese P . Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses. Virology. 1988; 163(1):112-22. DOI: 10.1016/0042-6822(88)90238-3. View

16.

Hogan T . Issues in the economic evaluation of influenza vaccination by injection of healthy working adults in the US: a review and decision analysis of ten published studies. Pharmacoeconomics. 2012; 30(5):355-71. DOI: 10.2165/11596890-000000000-00000. View

17.

Piedra P, Gaglani M, Riggs M, Herschler G, Fewlass C, Watts M . Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics. 2005; 116(3):e397-407. PMC: 1361119. DOI: 10.1542/peds.2004-2258. View

18.

Treanor J, Talbot H, Ohmit S, Coleman L, Thompson M, Cheng P . Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis. 2012; 55(7):951-9. PMC: 3657521. DOI: 10.1093/cid/cis574. View

19.

Loeb M, Russell M, Moss L, Fonseca K, Fox J, Earn D . Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA. 2010; 303(10):943-50. DOI: 10.1001/jama.2010.250. View

20.

Poehling K, Edwards K, Griffin M, Szilagyi P, Staat M, Iwane M . The burden of influenza in young children, 2004-2009. Pediatrics. 2013; 131(2):207-16. PMC: 3557405. DOI: 10.1542/peds.2012-1255. View